INSP SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces that Inspire Medical Systems Investors Have Opportunity to Lead Class Action Lawsuit

Core Viewpoint - Inspire Medical Systems is facing a class action lawsuit due to alleged violations of federal securities laws, including making false statements about the demand and launch of its Inspire V device [6][9]. Group 1: Legal Action and Investigation - Faruqi & Faruqi, LLP is investigating potential claims against Inspire Medical Systems and has set a deadline of January 5, 2026, for investors to seek the role of lead plaintiff in the class action lawsuit [3]. - Investors who suffered losses between August 6, 2024, and August 4, 2025, are encouraged to contact the law firm to discuss their legal rights [2][3]. Group 2: Company Performance and Issues - On August 4, 2025, Inspire Medical announced significant setbacks in the launch of its Inspire V device, citing delays in training and onboarding at treatment centers [7]. - The company faced billing and reimbursement challenges, as necessary software updates for claims processing were not implemented until July 1, 2025, preventing centers from billing for procedures [8]. - Inspire Medical reported weak demand and excess inventory for the Inspire V device, leading to a more than 80% cut in its 2025 earnings guidance [9]. - Following these announcements, Inspire's stock price plummeted over 32% in one day, resulting in a loss of approximately $1.2 billion in market capitalization [9].